Site Contents for Indication Areas created on 2009-09-11 - most recent items first

'Antihormonal Therapies Market Forecast' Interactive Model by Datamonitor: published July 2009
'Antihypertensives Market Forecast' Interactive Model by Datamonitor: published August 2009
'Stakeholder Opinions: Skin and soft tissue infections' Report by Datamonitor: published July 2009

'Psoriasis Market Forecast' Interactive Model by Datamonitor: published July 2009
'Obesity Market Forecast' Interactive Model by Datamonitor: published July 2009
'Seasonal Influenza Vaccines Market Forecast' Interactive Model by Datamonitor: published August 2009
'Inflammatory Bowel Disease Market Forecast' Book by Datamonitor: published July 2009
'World Sleep Disorders Market Analysis 2009-2024' Management Report by Visiongain: published June 2009
'World Respiratory Disorders Market 2009-2024' Management Report by Visiongain: published June 2009
'Monoclonal Antibodies in Cancer Therapy 2009-2024' Management Report by Visiongain: published May 2009
'Forecast Insight: Attention-Deficit Hyperactivity Disorder - Shire to stay on top despite drug safet' Report by Datamonitor: published July 2009
'Fibromyalgia Market Forecast' Interactive Model by Datamonitor: published June 2009
'Forecast Insight: HIV - Cross-class fixed dose combinations drive continued growth' Report by Datamonitor: published June 2009
'Commercial Insight: Cytotoxic Therapies - Market growth will slow due to increasing genericization' Report by Datamonitor: published June 2009
'Commercial Insight: Asthma & COPD - On the verge of generic entry' Report by Datamonitor: published June 2009
'Attention-Deficit Hyperactivity Disorder Market Forecast' Interactive Model by Datamonitor: published July 2009
'Forecast Insight: Inflammatory Bowel Disease - New product launches sustain long-term market growth' Report by Datamonitor: published June 2009
'Cytotoxic Therapies Market Forecast' Interactive Model by Datamonitor: published June 2009
'The Pain Management Market Outlook To 2014: Competitive landscape, pipeline analysis and growth oppo' Report by Business Insights: published June 2009
'HIV Market Forecast' Interactive Model by Datamonitor: published June 2009
'Asthma and COPD Market Forecast' Interactive Model by Datamonitor: published June 2009
'The Global Market for Pain Management Drugs and Devices' Market Study by Business Communications Company Inc.: published June 2007
'Liver Disease Treatments: The Global Market' Market Study by Business Communications Company Inc.: published June 2009
'Cancer Therapies: Technologies and Global Markets' Market Study by Business Communications Company Inc.: published May 2008
'Global Medical Markets for Nanoscale Materials and Devices' Market Study by Business Communications Company Inc.: published August 2008
'Animal Therapeutics and Diagnostics' Market Study by Business Communications Company Inc.: published July 2008
'Anti-aging Products and Services: The Global Market' Market Study by Business Communications Company Inc.: published May 2009
'Who's Developing What in Cardiovascular Devices?' Market Briefing by Espicom: published November 2008
'CNS Drug Discoveries: Multiple Sclerosis Chapter' Market Briefing by Espicom: published August 2008
'CNS Drug Discoveries: Depression Chapter' Market Briefing by Espicom: published August 2008
'CNS Drug Discoveries: what the future holds 2008 FULL REPORT' Market Briefing by Espicom: published August 2008
'CNS Drug Discoveries: Parkinson's Disease Chapter' Market Briefing by Espicom: published August 2008
'The Orthopaedic Company Review' Market Briefing by Espicom: published December 2008
'CNS Drug Discoveries: Alzheimer's Disease Chapter' Market Briefing by Espicom: published August 2008
'The Global Market for Advanced Wound Care Products 2009' Market Briefing by Espicom: published April 2008
'CNS Drug Discoveries: Schizophrenia Chapter' Market Briefing by Espicom: published August 2008
'Forecast Insight: Fibromyalgia - Regulatory caution threatens EU market expansion' Report by Datamonitor: published June 2009
'Global Coronary Stent Market Report' Management Report by Koncept Analytics: published May 2009
'Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs' Management Report by Koncept Analytics: published March 2009
'Oral Contraceptives & Condom Market: An Analysis' Management Report by Koncept Analytics: published March 2009
'Indian Oral Care Market: Low Penetration Offers Growth Opportunities' Management Report by Koncept Analytics: published April 2008
'Indian Aesthetic (Cosmetic Surgery) Industry: A Primer' Management Report by Koncept Analytics: published May 2008
'Global HIV Market: An Analysis' Management Report by Koncept Analytics: published February 2009
'Innovation Driving Trauma Market' Management Report by Koncept Analytics: published June 2008
'Global Dialysis Market Report: 2009 Edition' Management Report by Koncept Analytics: published February 2009
'Global Ophthalmic Market: Focus on Glaucoma ' Management Report by Koncept Analytics: published January 2009
'Global Intravenous (IV) Iron Drugs Market: Potential Opportunities' Management Report by Koncept Analytics: published February 2009
'Global In Vitro Diagnostics (IVD) Market: An Analysis' Management Report by Koncept Analytics: published January 2009
'Global Radiation Therapy Market: 2008 Edition' Management Report by Koncept Analytics: published November 2008
'Competition Driving Breakthroughs in Sports Medicine Market' Management Report by Koncept Analytics: published March 2008
'Urinary Incontinence Devices Market: An Analysis' Management Report by Koncept Analytics: published April 2009
'Global Spine Market Report: 2009 Edition' Management Report by Koncept Analytics: published February 2009
'Worldwide Heart Valve Market: Focus on Tissue Valves' Management Report by Koncept Analytics: published May 2008
'Worldwide Heart Valve Market Report: 2009 Edition' Management Report by Koncept Analytics: published May 2009
'Market for Tissue Implant Applications' Management Report by Koncept Analytics: published June 2008
'Global Alzheimer Drugs Market: An Analysis' Management Report by Koncept Analytics: published March 2009
'Chronic Obstructive Pulmonary Disease (COPD) Market: An Analysis' Management Report by Koncept Analytics: published May 2009
'Worldwide Cancer Market: Trend Analysis' Management Report by Koncept Analytics: published June 2008
'Undiagnosed Sleep Disorder Market Offers Growth Opportunities' Management Report by Koncept Analytics: published April 2008
'Stakeholder Opinions: Narcolepsy - Entry-point to a lucrative fatigue-associated market : Datamonito' Report by Datamonitor: published December 2008
'Pipeline Insight: Orphan Diseases in CNS - Part II: Amyotrophic Lateral Sclerosis : Datamonitor' Report by Datamonitor: published December 2007
'Pipeline Insight: Substance Dependence - Part II: Alcohol : Datamonitor' Report by Datamonitor: published December 2007
'Stakeholder Opinions: Endometriosis - Scientific clarity will unlock market potential : Datamonitor' Report by Datamonitor: published December 2007
'Pipeline perspectives: Peripheral artery disease Poor disease awareness hinders new agents : Datamo' Report by Datamonitor: published December 2007
'Stakeholder Insight: Inflammatory Bowel Disease - Debate over early aggressive treatment continues ' Report by Datamonitor: published December 2007
'Stakeholder Opinions: Heart Failure - When drugs do not work : Datamonitor' Report by Datamonitor: published April 2008
'MarketWatch: CNS : Datamonitor' Brief by Datamonitor: published July 2008
'MarketWatch: Cancer : Datamonitor' Brief by Datamonitor: published July 2008
'Stakeholder Opinions: Hepatitis C - Small-molecule antivirals pave the way for triple therapy : Data' Report by Datamonitor: published December 2007
'Stakeholder Insight: Parkinson's Disease - Evidence of neuroprotection essential to progress treatme' Report by Datamonitor: published December 2007
'MarketWatch: Health Round-up : Datamonitor' Brief by Datamonitor: published July 2008
'Stakeholder Opinions: Multiple Myeloma - Exploring new targets for multiple drug therapy : Datamonit' Report by Datamonitor: published December 2007
'Stakeholder Opinions: Myelodysplastic Syndromes - First approvals spur some interest in a niche mark' Report by Datamonitor: published December 2007
'Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture' Report by Datamonitor: published December 2007
'Stakeholder Opinions: Non-Hodgkin's Lymphoma - Is there room to emulate Rituxan's success? : Datamon' Report by Datamonitor: published December 2007
'MarketWatch: Health Round-up : Datamonitor' Brief by Datamonitor: published May 2008
'MarketWatch: CNS : Datamonitor' Brief by Datamonitor: published May 2008
'MarketWatch: Cancer : Datamonitor' Brief by Datamonitor: published May 2008
'Pipeline and Commercial Insight: Urinary Incontinence - Lifecycle management strategies retain mid-t' Report by Datamonitor: published December 2007
'Commercial Insight: Infectious Diseases Overview : Datamonitor' Report by Datamonitor: published December 2007
'Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses : Datamonitor' Report by Datamonitor: published May 2008
'Forecast Insight: Parkinson's Disease - Market upgrade following evidence of disease slowing with Az' Report by Datamonitor: published September 2008
'Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents d' Report by Datamonitor: published April 2008
'Commercial Insight: Autoimmune Overview - Market continues to prosper : Datamonitor' Report by Datamonitor: published December 2007
'Pipeline Insight: Acute Stroke: Commercial risk offsets high unmet need : Datamonitor' Report by Datamonitor: published May 2008
'Pipeline Insight: Non-insulin antidiabetics – Incretin mimetics – leaders in a diverse pipeline : Da' Report by Datamonitor: published May 2008
'Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prosp' Report by Datamonitor: published July 2008
'Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities' Report by Datamonitor: published July 2008
'MarketWatch: Health Round-up : Datamonitor' Brief by Datamonitor: published August 2008
'Stakeholder Insight: Diabetes : Datamonitor' Report by Datamonitor: published December 2007
'Commercial and Pipeline Insight: Fibromyalgia - Approvals legitimize condition and expose underserve' Report by Datamonitor: published July 2008
'Stakeholder Insight: Asthma - Over-prescribing is common in intermittent and mild forms of asthma : ' Report by Datamonitor: published July 2008
'MarketWatch: Cancer : Datamonitor' Brief by Datamonitor: published June 2008
'Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tep' Report by Datamonitor: published June 2008
'Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players :' Report by Datamonitor: published June 2008
'MarketWatch: Health Round-up : Datamonitor' Brief by Datamonitor: published June 2008
'MarketWatch: CNS : Datamonitor' Brief by Datamonitor: published June 2008
'Commercial Insight: Inflammatory Bowel Disease - Convenience and compliance drive market success : D' Report by Datamonitor: published September 2008
'Stakeholder Opinions: Diagnostics in Neurology - Predictive biomarkers expand drug revenues : Datamo' Report by Datamonitor: published July 2008
'MarketWatch: CNS : Datamonitor' Report by Datamonitor: published March 2008
'MarketWatch: Health Round-up : Datamonitor' Report by Datamonitor: published March 2008
'Pipeline and Commercial Insight: Alzheimer's Disease - Scenario forecasts reveal vast market potenti' Report by Datamonitor: published March 2008
'Commercial Insight: Select herpes viruses and human papilloma virus - Non-biologic interventions for' Report by Datamonitor: published August 2008
'Forecast Insight: Antidiabetics - Switching to new molecule antidiabetics drives market growth : Dat' Report by Datamonitor: published August 2008
'Commercial Insight: Solid organ transplantation - The impact of new biologics, generics and reformul' Report by Datamonitor: published December 2008
'Stakeholder Opinions: Sepsis - The Critical Care Community Gains Critical Mass : Datamonitor' Report by Datamonitor: published March 2008
'Stakeholder Opinions: Portable Inhaler Devices - Key tools to differentiate brands and survive gener' Report by Datamonitor: published April 2008
'MarketWatch: Cancer : Datamonitor' Report by Datamonitor: published April 2008
'MarketWatch: Health Round-up : Datamonitor' Report by Datamonitor: published April 2008
'Forecast Insight: Multiple Sclerosis - Tysabri to prevail despite safety setbacks : Datamonitor' Report by Datamonitor: published August 2008
'Commercial Insight: Antihormonal Therapy Cancer Brands - Careful lifecycle management needed to pres' Report by Datamonitor: published August 2008
'Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment ' Report by Datamonitor: published March 2008
'MarketWatch: Cancer : Datamonitor' Report by Datamonitor: published March 2008
'MarketWatch: CNS : Datamonitor' Report by Datamonitor: published February 2008
'MarketWatch: Cancer : Datamonitor' Report by Datamonitor: published February 2008
'MarketWatch: Health Round-up : Datamonitor' Report by Datamonitor: published February 2008
'Stakeholder Opinions: Head and Neck Cancer : Datamonitor' Report by Datamonitor: published November 2007
'Stakeholder Opinions: Alpha 1 Antitrypsin Deficiency : Datamonitor' Report by Datamonitor: published December 2007
'Stakeholder Opinions: Systemic Lupus Erythematosus - Market set to enter era of biologic therapies :' Report by Datamonitor: published March 2008
'Stakeholder Opinions: Bone Metastases - Impending patent expiries may help make or break newer agent' Report by Datamonitor: published March 2008
'Stakeholder Opinions: Biologics in Infectious Diseases Well defined target populations are key to c' Report by Datamonitor: published March 2008
'Forecast Insight: Migraine - Generic incursion inhibits market growth : Datamonitor' Report by Datamonitor: published December 2008
'Stakeholder Insight: Infertility - Undifferentiated drugs force need to strengthen prescriber and pa' Report by Datamonitor: published December 2008
'Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine? : Datamonitor' Report by Datamonitor: published April 2008
'MarketWatch: CNS : Datamonitor' Brief by Datamonitor: published August 2008
'MarketWatch: Cancer : Datamonitor' Brief by Datamonitor: published August 2008
'Forecast Insight: Asthma/COPD - Little long-term future for long-acting single-agent inhalers? : Dat' Report by Datamonitor: published August 2008
'Forecast Insight: Antihypertensives Key patent expiries prevent market growth : Datamonitor' Report by Datamonitor: published July 2008
'Pipeline Insight: Cancer Overview - Lung, Brain, Head and Neck, Thyroid : Datamonitor' Report by Datamonitor: published July 2008
'Commercial Insight: Targeted Therapy Cancer Brands - High growth market will see eight new blockbust' Report by Datamonitor: published July 2008
'Pipeline Insight: HIV - Novel NNRTIs address crucial unmet need : Datamonitor' Report by Datamonitor: published December 2007
'Commercial Insight: Cytotoxic Therapy Cancer Brands - Looming patent expiries limit market growth : ' Report by Datamonitor: published July 2008
'Commercial Insight: HIV - The battle for market share is getting fiercer : Datamonitor' Report by Datamonitor: published August 2008
'MarketWatch: CNS : Datamonitor' Report by Datamonitor: published April 2008
'Forecast Insight: Insomnia Orexin and serotonin receptor modulators to innovate market : Datamonito' Report by Datamonitor: published August 2008
'Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial' Report by Datamonitor: published April 2008
'Pipeline and Commercial Insight: Hepatitis C - High unmet need drives rapid innovation : Datamonitor' Report by Datamonitor: published December 2008
'Forecast Insight: Depression - Generic induced brand erosion leads to market decline : Datamonitor' Report by Datamonitor: published December 2008
'Pipeline Insight: Cancer Overview - Gastrointestinal, Skin, Sarcomas : Datamonitor' Report by Datamonitor: published December 2008
'Commercial and Pipeline Insight: HRT for Menopausal Symptoms – A new class restores an old market : ' Report by Datamonitor: published April 2008
'Stakeholder Insight: Prostate Cancer - Hormone-refractory patients still waiting for treatment break' Report by Datamonitor: published December 2007
'Commercial Insight: CNS Market Overview - Commercial dynamics and outlook of the neurology, pain and' Report by Datamonitor: published April 2008
'Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates : Datamo' Report by Datamonitor: published April 2008
'Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements : Data' Report by Datamonitor: published April 2008
'Pipeline Insight: Insulin antidiabetics - Return to injections alternative delivery methods fall by' Report by Datamonitor: published July 2008
'Stakeholder Insight: Systemic Lupus Erythematosus Imprecise segmentation complicates treatment algo' Report by Datamonitor: published November 2008
'Pipeline Insight: Molecular Targeted Cancer Therapies - More pipeline activity, less product differe' Report by Datamonitor: published November 2008
'Stakeholder Insight: Chronic Leukemias - Is there room left for improvement? : Datamonitor' Report by Datamonitor: published November 2008
'Stakeholder Opinions: Restless Legs Syndrome - Novel drugs to prosper as lifecycle management strate' Report by Datamonitor: published November 2008
'Pipeline and Commercial Insight: Anxiety Disorders - Viable indication for antipsychotics companies ' Report by Datamonitor: published November 2008
'Forecast Insight: Dyslipidemia - Genericization and negative trial data drive market shrinking : Dat' Report by Datamonitor: published August 2008
'Stakeholder Opinions: Bladder Cancer - New drugs needed to challenge ineffective 20-year old drugs :' Report by Datamonitor: published November 2008
'Stakeholder Opinions: Diabetic Renal Disease : Datamonitor' Report by Datamonitor: published November 2008
'Pipeline Insight: Orphan Diseases in Neurology - Part III: Myasthenia Gravis : Datamonitor' Report by Datamonitor: published November 2008
'MarketWatch: Cancer : Datamonitor' Brief by Datamonitor: published September 2008
'Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching' Report by Datamonitor: published September 2008
'MarketWatch: Health Round-up : Datamonitor' Brief by Datamonitor: published September 2008
'MarketWatch: CNS : Datamonitor' Brief by Datamonitor: published September 2008
'Global Cancer Treatment Forecast to 2012' Management Report by RNCOS: published August 2008
'Booming Global Obesity Drug Market' Management Report by RNCOS: published December 2008
'Pipeline Insight: Mild Cognitive Impairment - Unlocking the potential of prodromal Alzheimer's disea' Report by Datamonitor: published April 2009
'Stakeholder Opinions: Celiac Disease - Licensing opportunities exist in untapped market : Datamonito' Report by Datamonitor: published April 2009
'Stakeholder Opinions: Commercial strategies in cardiovascular and metabolic diseases successful mar' Report by Datamonitor: published April 2009
'The Global Multiple Sclerosis Market 2009-2024 :: Visiongain' Management Report by Visiongain: published March 2009
'Anti-Obesity Treatments Report - Analysis & Forecasts 2009-2024' Management Report by Visiongain: published February 2009
'Stakeholder Opinions: Back Pain - Gain competitive edge by targeting subpopulations' Market Study by Datamonitor: published March 2009
'Stakeholder Opinions: Pulmonary Arterial Hypertension clinical community builds order from chaos' Market Study by Datamonitor: published March 2009
'Stakeholder Opinions: Pancreatic Cancer - Gemzar dominance will continue among high levels of persis' Market Study by Datamonitor: published March 2009
'Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life' Market Study by Datamonitor: published March 2009
'The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities' Market Study by Business Insights: published April 2009
'The Asian Cardiovascular Market Outlook to 2014: Regional and therapeutic analysis, pipeline impact ' Market Study by Business Insights: published March 2009
'Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets' Market Study by TriMark Publications: published April 2009
'Avian Influenza' Management Report by TriMark Publications: published August 2006
'DNA Sequencing and PCR Markets' Market Study by TriMark Publications: published July 2008
'Sleep Disorders: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking' Market Study by TriMark Publications: published March 2009
'Nuclear Cardiology Markets' Market Study by TriMark Publications: published December 2007
'Veterinary Health Markets' Market Study by TriMark Publications: published December 2008
'Animal Health Products Antibacterials Markets ' Market Study by TriMark Publications: published May 2008
'Blood Gas Instrumentation Data Processing' Market Study by TriMark Publications: published September 2004
'Osteoporosis & Bone Metabolism Disorders Market 2008-2023 Management Report' Management Report by Visiongain: published August 2008
'Women's Reproductive Disorders Therapeutics 2008-2018' Management Report by Visiongain: published September 2008
'World Gastrointestinal Disorders Market 2008-2023' Management Report by Visiongain: published October 2008
'The Global Anti-Addiction Market, 2008-2023' Management Report by Visiongain: published November 2008
'The Global Pain Market, 2008-2023' Management Report by Visiongain: published November 2008
'The World Dermatological Market Outlook, 2009-2023' Management Report by Visiongain: published January 2009
'The Autoimmune Inflammatory Bowel Disease Market Outlook to 2012' Management Report by Visiongain: published February 2007
'Anti-addiction Therapies, 2006-2011 The Pharmaceutical Industry's Next Viagra?' Management Report by Visiongain: published October 2006
'The World Allergy Market 2006-2011: The Rx-OTC Rush' Management Report by Visiongain: published September 2006
'The Global Non-Opioid Market in Pain Management, 2007-2022' Management Report by Visiongain: published October 2007
'The World Asthma and COPD Treatment Market, 2006-2011: A Changing Market with Increasing Potential' Management Report by Visiongain: published August 2006
'The Global Rheumatoid Arthritis Market Forecasts to 2012' Management Report by Visiongain: published March 2007
'Global Ophthalmic Market Analysis & Forecasts to 2012' Management Report by Visiongain: published April 2007
'Parkinson's Disease: Market analysis and forecasts, 2008-2012, 2017 & 2022' Management Report by Visiongain: published January 2008
'Lou Gehrig Disease Report: Is there a link between Lipitor and ALS?' Management Report by Visiongain: published August 2007
'Multiple Sclerosis Market Analysis & Forecasts Report 2007-2022' Management Report by Visiongain: published August 2007
'The World Hypertension Market 2007-2023' Management Report by Visiongain: published September 2007
'Sleep Disorders: Market Analysis 2008-2018' Management Report by Visiongain: published March 2008
'The Antibacterial Drug Market: Analysis 2008-2013' Management Report by Visiongain: published March 2008
'Anti-Obesity Treatments 2007-2012: A blockbuster target market' Management Report by Visiongain: published July 2007
'Global Smoking Cessation Market Analysis & Forecasts - Preparing for the first blockbuster' Management Report by Visiongain: published July 2007
'Alzheimer's Disease Market analysis and forecasts, 2007-2012, 2017 & 2022' Management Report by Visiongain: published October 2007
'The Anti-Migraine Market 2007-2022' Management Report by Visiongain: published November 2007
'The World Diabetes Market, 2007-2025: A Key Pharmaceutical Market of the Future' Management Report by Visiongain: published October 2007
'Gastrointestinal Disorders Market Intelligence to 2012' Management Report by Visiongain: published May 2007
'Respiratory Market Insight 2008' Management Report by Visiongain: published February 2008
'Neurodegenerative Disease Drug Market Analysis and Forecasts 2007' Management Report by Visiongain: published June 2007
'Erectile Dysfunction Market Assessment & Analysis 2007-2022' Management Report by Visiongain: published December 2007
'The World Dermatological Market Analysis & Forecasts 2007-2022' Management Report by Visiongain: published November 2007
'The Global Pain Pharmaceutical Market Analysis & Forecasts 2007-2022' Management Report by Visiongain: published September 2007
'Antithrombotics Market Forecast' Market Study by Datamonitor: published January 2009
'Hepatitis C Market Forecast' Market Study by Datamonitor: published January 2009
'Stakeholder Opinions: Sarcomas' Market Study by Datamonitor: published December 2008
'Forecast Insight: Epilepsy - Future market upgrade following new drug launches' Market Study by Datamonitor: published December 2008
'Stakeholder Insight: Psoriasis - Biologics are yet to make topical treatments obsolete' Market Study by Datamonitor: published March 2009
'Stakeholder Opinions: Cystic Fibrosis - A pipeline full of hope' Market Study by Datamonitor: published March 2009
'CV & Diabetes Market Forecast' Market Study by Datamonitor: published January 2009
'The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipelin' Market Study by Business Insights: published January 2009
'Stakeholder Insight: Acute Coronary Syndromes ACS in Europe, what is the best practice?' Market Study by Datamonitor: published December 2008
'Commercial Insight: Rheumatoid arthritis - Anti-TNFs defend first-line biologic position despite com' Market Study by Datamonitor: published January 2009
'Commercial Insight: Cardiovascular and metabolic market overview Diabetes to the fore as generics h' Market Study by Datamonitor: published February 2009
'Stakeholder Opinions: Cancer Cachexia - Higher profile needed to unlock market potential of neglecte' Market Study by Datamonitor: published January 2009
'Stakeholder Opinions: Physician perception of biologics in autoimmune disease - Targeted detailing i' Market Study by Datamonitor: published March 2009
'Stakeholder Insight: Spondyloarthropathies - Disease perception limits market potential' Market Study by Datamonitor: published December 2008
'Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia Growth opportunities in fragmen' Market Study by Datamonitor: published December 2008
'Introgen Therapeutics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Intarcia Therapeutics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Inex Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Keryx Biopharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Lorus Therapeutics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Kirin Brewery Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Glycogenesys Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Kyowa Hakko Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Kosan Biosciences Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Isis Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Immunomedics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Immunogen Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Genaera Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Favrille Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Gamida-Cell Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Exelixis Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Chiron Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Epicept Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published January 2006
'Cyclacel Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Cytokinetics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Endocyte Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Entremed Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Eli Lilly Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Genentech Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published March 2006
'Genitope Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Genvec Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Human Genome Sciences Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Hybridon Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'IDM Pharma Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Daiichi Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Imclone Systems Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Hana Biosciences Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published February 2006
'Genzyme Oncology Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Geron Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Glaxosmithkline Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'GPC Biotech Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Genta Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Dendreon Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'CNS Drug Discoveries: what the future holds Sleep Disorders Chap' Management Report by Espicom Business Intelligence: published November 2006
'Cancer Drug Discoveries: what the future holds FULL REPORT' Market Study by Espicom Business Intelligence: published May 2007
'Xenova Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'YM B ioSciences Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published May 2006
'Viventia Biotech Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Wilex Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'ViRexx Medical Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Vion Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Vical Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Topotarget Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Transgene Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Vernalis Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Supergen Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Synta Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Telik Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Therion Biologics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Aeterna Zentaris Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Drug Delivery Technology: Revolutionizing Cancer Therapies' Management Report by Espicom Business Intelligence: published May 2007
'Emerging Opportunities in Cancer Nanomedicine' Management Report by Espicom Business Intelligence: published August 2006
'New Drug Futures: Cancer Chapter' Management Report by Espicom Business Intelligence: published May 2006
'CNS Drug Discoveries: what the future holds FULL REPORT' Market Study by Espicom Business Intelligence: published November 2006
'CNS Drug Discoveries: Schizophrenia Chapter' Management Report by Espicom Business Intelligence: published November 2006
'CNS Drug Discoveries: Neurodegenerative Disorders Chapter' Management Report by Espicom Business Intelligence: published November 2006
'CNS Drug Discoveries: Multiple Sclerosis Chapter' Management Report by Espicom Business Intelligence: published November 2006
'CNS Drug Discoveries: Depression Chapter' Management Report by Espicom Business Intelligence: published November 2006
'CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder (' Management Report by Espicom Business Intelligence: published November 2006
'Cancer Vaccine Developments to 2013' Market Study by Espicom Business Intelligence: published September 2007
'Cancer Vaccine Developments to 2013' Market Study by Espicom Business Intelligence: published September 2007
'Cancer Drug Discoveries: what the future holds: Prostate Cancer ' Management Report by Espicom Business Intelligence: published May 2007
'Cancer Drug Discoveries: what the future holds: Renal Cancer Cha' Management Report by Espicom Business Intelligence: published May 2007
'Cancer Drug Discoveries: what the future holds: Non-Small Cell L' Management Report by Espicom Business Intelligence: published May 2007
'Cancer Drug Discoveries: what the future holds: Breast Cancer Ch' Management Report by Espicom Business Intelligence: published May 2007
'Cancer Drug Discoveries: what the future holds: Colorectal Cance' Management Report by Espicom Business Intelligence: published May 2007
'World Cancer Market Yearbook 2005' Market Briefing by Espicom Business Intelligence: published December 2005
'Who's Developing What in New Cancer Drugs?' Market Briefing by Espicom Business Intelligence: published November 2007
'What's Hot in Cancer Drug R&D?' Market Briefing by Espicom Business Intelligence: published July 2006
'Roche Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published February 2006
'Sanofi-Aventis Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Schering-Plough Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Novartis Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published April 2006
'ONCOGENEX TECHNOLOGIES Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Neopharm Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Northwest Biotherapeutics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Millennium Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Nemod Immunotherapie Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Merck KgaA Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Methylgene Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Mgi Pharma Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Micromet Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published May 2006
'Marshall Edwards Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Maxim Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Medarex Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Medigene Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Medimmune Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Meditech Research Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Novacea Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Oxford Biomedica Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Biomira Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Seattle Genetics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Spectrum Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Pharmacyclics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Pharmamar Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Photocure Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Praecis Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Progen Industries Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Progenics Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Protherics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Oxigene Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Panacea Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Peregrine Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Pfizer Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Oncolytics Biotech Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Onyvax Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Osi Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Ligand Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Clavis Pharma Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Medical Market Futures to 2011 – Option 2: Report Only' Market Briefing by Espicom Business Intelligence: published January 2007
'Antigenics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Anticancer Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Anosys Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Anormed Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Angiogene Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Amgen Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Ambrilia Biopharma Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published March 2006
'Arius Research Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Ariad Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Access Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Active Biotech Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Medical Market Futures to 2011 – Option 1: Report+Data (csv file' Market Briefing by Espicom Business Intelligence: published September 2006
'Regional Volume III: Americas' Market Briefing - July 2007 by Espicom Business Intelligence: published July 2007
'The Global Market for Advanced Wound Care Products 2007' Market Briefing - March 2007 by Espicom Business Intelligence: published March 2007
'Regional Volume IV: Asia Pacfic' Market Briefing - July 2007 by Espicom Business Intelligence: published July 2007
'The World Medical Markets Fact Book 2007' Market Briefing - March 2007 by Espicom Business Intelligence: published March 2007
'Emerging Technologies in Spinal Motion Preservation' Market Briefing by Espicom Business Intelligence: published June 2007
'Allos Therapeutics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Alfacell Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Adventrx Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Aphton Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Antisoma Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Antisense Pharma Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Bristol-Myers Squibb Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Biovex Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Bionumerik Pharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Coley Pharmaceutical Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Cephalon Company Intelligence Report (FORMERLY Salmedix)' Market Briefing by Espicom Business Intelligence: published September 2005
'Collgard Biopharmaceuticals Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Cel-Sci Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Celgene Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Cell Therapeutics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Btg Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Can-Fite Biopharma Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Avax Technologies Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Attenuon Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Astrazeneca Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published February 2006
'Arqule Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Ark Therapeutics Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Biogen Idec Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Bioenvision Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Bayer Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published July 2006
'Avi Biopharma Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Cell Genesys Cancer Company Intelligence Report' Market Briefing by Espicom Business Intelligence: published September 2005
'Immunotherapy of Cancer' Management Report by BCC Research: published March 2007
'Drug Treatments for Leading Endocrine and Metabolic Diseases' Management Report by BCC Research: published February 2007
'World Market for Cancer Vaccines 2007-2012' Management Report by Visiongain: published January 2007
'Cancer Overview - Emerging therapeutic and commercial' Market Study by Datamonitor: published July 2006
'The Global Diabetes Market: Therapeutics, Diagnostics and' Market Briefing by Arrowhead Publishers: published August 2006
'Commercial Insight Top 20 Cancer Therapeutics' Market Study by Datamonitor: published July 2006
'An Evaluation of Products and Technologies for Molecular' Market Briefing by HBS Consulting: published May 2006
'Stakeholder Opinions: Gastric Cancer - Targeted Therapies Home' Management Report by Datamonitor: published March 2006
'The Eastern European Cancer Market Outlook to 2010' Market Briefing by Business Insights: published December 2005
'Kinase Inhibitors' Market Study by Business Communications Company Inc.: published January 2006
'The World Hypertension Market 2005-2010' Market Study by Visiongain: published November 2005
'Antidyslipidemics - Statins Hit the Brakes on Market Growth' Management Report by Datamonitor: published December 2005
'Pain Therapeutics 2005' Management Report by Arrowhead Publishers: published May 2005
'Cancer Therapeutics 2006: Market Dynamics and R&D Trends' Management Report by Arrowhead Publishers: published December 2005
'Biogenerics' Management Report by Arrowhead Publishers: published November 2004
'Commercial Insight: HIV - Simplicity and Survival' Market Study by Datamonitor: published August 2005
'Stem Cell Therapies and Regenerative Medicine: Current Applicati' Market Study by Business Communications Company Inc.: published December 2005
'Stem Cell Therapies and Regenerative Medicine: Current Applicati' Market Study by Business Communications Company Inc.: published December 2005
'Cancer Therapies to 2009' Market Study by Freedonia: published November 2005
'Freedonia Focus on Soy Products & Markets' Management Report by Freedonia: published October 2005
'Commercial Insight: Cancer Market Top 20 Drugs - Supportive Care' Market Study by Datamonitor: published January 2005
'Stakeholder Opinions: Head and Neck Cancer - Innovatives to Chan' Book by Datamonitor: published February 2005
'Optimizing Targeted Treatment in Cancer: Negotiating the Challen' Management Report by Datamonitor: published September 2005
'U.S. Market for Gastrointestinal Pharmaceuticals' Management Report by Business Communications Company Inc.: published September 2005
'Emotional and Behavioral Disorders in Children and Adolescents' Management Report by Business Communications Company Inc.: published September 2005
'Dynamic Antibody' Management Report by Business Communications Company Inc.: published August 2005
'Top CNS Portfolios in 2004 - The Industry Gold Standards' Management Report by Datamonitor: published January 2005
'Adjunctive Therapies: Photodynamic, Electromagnetic, Radioimmuno' Market Study by Business Communications Company Inc.: published December 2004
'U.S. Ethical Drug Market: Strategies for Sustained Growth' Market Study by Business Communications Company Inc.: published April 2004
'Market Leaders in Oncology 2004 - Roche and Genentech Continue t' Management Report by Datamonitor: published January 2005
'DNA/RNA Therapies: Translating the Genome into a $1.2bn Market b' Market Study by Datamonitor: published February 2005
'Patient Monitoring Devices (report)' Market Study by Business Communications Company Inc.: published October 2003
'HIV - Reaching the 'Untapped' Patient Population' Market Study by Datamonitor: published November 2003
'Life Science Informatics: Strategies & Business Models (report)' Market Study by Datacomm Research: published May 2003
'EEG Processor Monitor: Strategies, and Forecasts, 2003 to 2008 (' Market Study by Wintergreen Research: published December 2003
'Commercial Perspectives: Anti-Hormonals - Tamoxifen to be Obsole' Market Study by Datamonitor: published February 2004
'Physician Insight Survey: 2003 Survey Results Overview' Market Study by Datamonitor: published December 2003
'Consumer Health Websites: A Guide to Positioning Consumer Health' Market Study by Datamonitor: published December 2003
'Antisense Products: Technology, Markets (report)' Market Study by Business Communications Company Inc.: published March 2003
'Biological, Chemical and Nuclear Terrorism: Diagnostic & Treatme' Market Study by Business Communications Company Inc.: published March 2003
'Telemedicine: Opportunities for Medical and Electronic Providers' Market Study by Business Communications Company Inc.: published March 2003
'The U.S. Clinical Diagnostic Equipment Market (report)' Market Study by Business Communications Company Inc.: published April 2003
'Trends in Noninvasive and Minimally Invasive Medical Device Mark' Market Study by Business Communications Company Inc.: published May 2003
'Medical Robotics and Computer Assisted Surgery Market (report)' Market Study by Business Communications Company Inc.: published June 2003
'The Market for In Vitro Toxicology Testing (report)' Market Study by Business Communications Company Inc.: published June 2003
'Medical Diagnostic Reagents, Carriers and Other Consumables (rep' Market Study by Business Communications Company Inc.: published September 2003
'The Dynamic Media, Sera and Reagent Market in the Cell Culture (' Market Study by Business Communications Company Inc.: published October 2003
'Breast Cancer Intelligence Package (package deal)' Market Study by Datamonitor: published June 2003
'Licensing/R&D Portfolio Package Deal' Market Study by Datamonitor: published June 2003
'Adult ADHD - Strattera Grows Up' Market Briefing by Datamonitor: published March 2004
'Bones and Joints: Drugs, Devices, and Regenerative Technologies' Market Study by Business Communications Company Inc.: published January 2001
'Innovative Agents in Lung and Colorectal Cancer - Another Step N' Market Briefing by Datamonitor: published April 2004
'eHealth Regulations in Europe: Understanding the Changing Europe' Market Briefing by Datamonitor: published April 2004
'Pharmaceutical Pricing Strategies' Market Briefing by Business Insights: published April 2005
'Beyond the Blockbuster Drug' Market Briefing by Business Insights: published February 2005